"Dimethyl Fumarate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS.
| Descriptor ID |
D000069462
|
| MeSH Number(s) |
D02.241.081.337.302.500
|
| Concept/Terms |
Dimethyl Fumarate- Dimethyl Fumarate
- Fumarate, Dimethyl
- 2-butenedioic acid, (2E)-, dimethyl ester
- Dimethylfumarate
BG 00012- BG 00012
- 00012, BG
- BG00012
- BG-00012
FAG 201- FAG 201
- 201, FAG
- FAG201
- FAG-201
BG 12 compound- BG 12 compound
- 12 compound, BG
- compound, BG 12
- BG12 compound
- compound, BG12
- BG-12 compound
|
Below are MeSH descriptors whose meaning is more general than "Dimethyl Fumarate".
Below are MeSH descriptors whose meaning is more specific than "Dimethyl Fumarate".
This graph shows the total number of publications written about "Dimethyl Fumarate" by people in this website by year, and whether "Dimethyl Fumarate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dimethyl Fumarate" by people in Profiles.
-
Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate. J Neurol. 2020 01; 267(1):125-131.
-
Progressive neurologic dysfunction in a psoriasis patient treated with dimethyl fumarate. Ann Neurol. 2015 Oct; 78(4):501-14.